Comment
the health of those who live in the poorest regions of the world disproportionately. Health professionals should have a powerful voice on climate change and environmental damage, personally and collectively.15 The health effects for those who live in the poorer areas of the world are a clear reminder of the consequences of the actions of more affluent nations. Rich countries also face increased health risks if they do not reduce their carbon emissions. The causal pathways that link illness and early death to the power dynamics and inequalities that underpin global poverty urgently need to be clarified and acted on: health professionals are in a key position to do this. As time runs out for some of the greatest threats to health such as climate change, it is imperative that they take action.
3 4
5
6
7
8
9
10
11
Marion Birch The Grayston Centre, 28 Charles Square, London N1 6HT, UK
[email protected] I am Director of Medact, which undertakes campaigning and policy work to expose the health costs of violent conflict, poverty, and environmental damage. 1 2
UN. Human development report 2006. 2006. http://hdr.undp.org/ hdr2006/pdfs/report/HDR06-complete.pdf (accessed Oct 16, 2007). Phipps S. The impact of poverty on health: a scan of research literature. June, 2003. http://dsp-psd.pwgsc.gc.ca/Collection/H118-11-2003-1E.pdf (accessed Oct 17, 2007).
12 13
14 15
Marmot M, Smith GD, Stansfeld S, et al. Health inequalities among British civil servants. Lancet 1991; 337: 1387–93. Davies JB, Sandstrom S, Shorrocks A, Wolff EN. The world distribution of household wealth. 2006. http://www.wider.unu.edu/research/2006-2007/ 2006-2007-1/wider-wdhw-launch-5-12-2006/wider-wdhw-report5-12-2006.pdf (accessed Oct 16, 2007). Global Health Watch. Global health watch 2005: an alternative health report. 2006: 12–13. http://www.ghwatch.org/2005report/ghw.pdf (accessed Oct 16, 2007). British Medical Association. Doctors—public confidence in doctors (Great Britain). November, 2006.http://bma.org.uk/ap.nsf/Content/DoctorsPublicPU (accessed Oct 16, 2007). Commission on Social Determinants of Health. The interim statement of the Commission on Social Determinants of Health. 2007: 55. http://www. who.int/social_determinants/resources/csdh_media/csdh_interim_ statement_07.pdf (accessed Oct 17, 2007). Robertson D. Why boom may not be bust after Iraq. Times (Lond) Aug 28, 2007. http://business.timesonline.co.uk/tol/business/industry_sectors/ engineering/article2337229.ece (accessed Oct 16, 2007). Stephan A. Iraq: the hidden cost of the war. New Statesman March 12, 2007. http://www.newstatesman.com/print/200703120024 (accessed Oct 16, 2007). UNICEF. State of the world’s children. 2006. http://www.unicef.org/ publications/files/The_State_of_the_Worlds__Children__2007_e.pdf (accessed Oct 16, 2007). Medact. Collateral damage: the health and environment costs of war on Iraq. 2002. http://www.medact.org/content/wmd_and_conflict/Medact_Iraq_ report%20(1).pdf (accessed Oct 16, 2007). UK Government. Gleneagles 2005: Chairman’s summary. http://www. number-10.gov.uk/output/Page7883.asp (accessed Oct 18, 2007). UK Home Office. Enforcing the rules: a strategy to ensure and enforce compliance with our immigration laws. Home Office, March 2007 http:// www.ind.homeoffice.gov.uk/6353/aboutus/EnforcementStrategy.pdf (accessed Oct 22, 2007). Yates T, Crane R, Burnett A. Rights and the reality of healthcare charging in the United Kingdom. Med Confl Surviv 2007; 23: 297–304. Stott R, Godlee F. What should we do about climate change? Health professionals need to act collectively and individually. BMJ 2006; 333: 983–84.
Cancer—a call for papers To submit a paper go to either http://ees.elsevier.com/thelancet or http://ees.elsevier.com/ thelancetoncology
1470
The development of innovative targeted treatments has become a major component of cancer research— understanding the genetic and molecular hallmarks of cancer cells has led to many new, highly efficacious therapeutic regimens. The Lancet and The Lancet Oncology are therefore issuing a joint call for papers, with an emphasis on targeted cancer treatments, to coincide with the next annual meeting of the American Society of Clinical Oncology (ASCO), to be held in Chicago, IL, USA, between May 30 and June 3, 2008. We welcome reports of original research that will have an important effect on clinical practice, and, in particular, articles that report the results of randomised phase II or III clinical trials. We are especially interested in research that will be presented at the ASCO annual meeting, but are also willing to consider other suitable articles; accepted manuscripts will be published to coincide with the conference.
If your article describes work that will be presented at the ASCO annual meeting, please tell us about the date, time, and nature of the presentation (ie, poster or oral). Publication in The Lancet or The Lancet Oncology will be scheduled to coincide with the presentation, and to comply with ASCO’s embargo policy. To respond to this call, please submit your work to us by March 14, 2008. Articles should be submitted via The Lancet’s or The Lancet Oncology’s online submission systems, and authors should state clearly in their covering letter that the submission is in response to the TL/TLO Call for Papers. Informal inquiries about the suitability of individual studies for publication are welcome. Richard Turner, Maja Zecevic, David Collingridge The Lancet, London NW1 7BY, UK (RT); The Lancet, New York, NY 10010, USA (MZ); and The Lancet Oncology, London NW1 7BY, UK (DC)
www.thelancet.com Vol 370 October 27, 2007